Display options
Cite
Ali L, Roos KL. Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS Drugs. 2002;16(12):799-802doi: 10.2165/00023210-200216120-00001.
Ali, L., & Roos, K. L. (2002). Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS drugs, 16(12), 799-802. https://doi.org/10.2165/00023210-200216120-00001
Ali, Latisha, and Roos, Karen L. "Antibacterial therapy of neurosyphilis: lack of impact of new therapies." CNS drugs vol. 16,12 (2002): 799-802. doi: https://doi.org/10.2165/00023210-200216120-00001
Ali L, Roos KL. Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS Drugs. 2002;16(12):799-802. doi: 10.2165/00023210-200216120-00001. PMID: 12421113.
Copy Download .nbib Format: NLM
Share it on

CNS Drugs. 2002;16(12):799-802. doi: 10.2165/00023210-200216120-00001.

Antibacterial therapy of neurosyphilis: lack of impact of new therapies.

CNS drugs

Latisha Ali, Karen L Roos

Affiliations

  1. Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

PMID: 12421113 DOI: 10.2165/00023210-200216120-00001

Abstract

Neurosyphilis is caused by the spirochete Treponema pallidum. These organisms divide slowly, requiring long exposure to antibacterials for treatment success. In order for an antibacterial to be effective in the therapy of neurosyphilis, it must achieve treponemicidal concentrations in the CSF, have a long half-life and be given in a treatment regimen that favours compliance. Penicillin was first introduced for the treatment of syphilis in 1943, and despite interest in the use of amoxicillin, erythromycin, tetracycline, doxycycline, ceftriaxone and azithromycin, penicillin remains the only recommended antibacterial agent for neurosyphilis.

References

  1. AMA Arch Neurol Psychiatry. 1959 May;81(5):557-90 - PubMed
  2. Semin Neurol. 1999;19 Suppl 1:35-40 - PubMed
  3. Sex Transm Dis. 1986 Jul-Sep;13(3 Suppl):185-8 - PubMed
  4. Clin Infect Dis. 1994 Mar;18(3):288-94 - PubMed
  5. Arch Neurol. 1985 Jun;42(6):606-13 - PubMed
  6. Sex Transm Dis. 1983 Jul-Sep;10(3):148-50 - PubMed
  7. Ann Neurol. 1979 Jul;6(1):68-9 - PubMed
  8. Ann Intern Med. 1988 Dec 1;109(11):855-62 - PubMed
  9. Sex Transm Dis. 1997 Mar;24(3):127-30 - PubMed
  10. Ann Intern Med. 1999 Sep 21;131(6):434-7 - PubMed
  11. Antimicrob Agents Chemother. 1985 Aug;28(2):347-8 - PubMed
  12. Br J Vener Dis. 1971 Jun;47(3):162-4 - PubMed
  13. Antimicrob Agents Chemother. 1982 Jun;21(6):984-9 - PubMed
  14. Clin Infect Dis. 2000 Mar;30(3):540-4 - PubMed
  15. Clin Infect Dis. 1999 Jan;28 Suppl 1:S21-8 - PubMed
  16. Sex Transm Infect. 1999 Aug;75 Suppl 1:S34-7 - PubMed
  17. Science. 1981 Jul 31;213(4507):553-5 - PubMed
  18. Am J Med. 1992 Nov;93(5):481-8 - PubMed
  19. N Engl J Med. 1992 Apr 16;326(16):1060-9 - PubMed
  20. Rev Infect Dis. 1985 May-Jun;7 Suppl 2:S314-7 - PubMed

Substances

MeSH terms

Publication Types